Marianne Yood, DSc
Adjunct Research Associate Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, Boston University School of Public Health
DSc, Boston University School of Public Health

Dr. Ulcickas Yood has more than 25 years professional experience in epidemiologic research. Her research focuses on pharmacoepidemiology and drug safety as well as methodologic issues relating to exposure measurement and data quality in large administrative databases. She collaborates with the Cancer Research Network to study cancer treatment effectiveness and sequelae. Dr. Ulcickas Yood has served on various advisory boards related to pharmacoepidemiology and drug safety and is currently a member of the Editorial Board for Pharmacoepidemiology and Drug Safety. She has published over 75 articles in numerous journals and is currently a co-investigator on 6 NIH funded grants. In addition, Dr. Ulcickas Yood is principal epidemiologist at EpiSource, an organization that designs and implements pharmacoepidemiology studies.

2011 International Society for Pharmacoepidemiology: Fellow
1999 Bristol-Myers Squibb: Excellence Award
1995 Society for Epidemiologic Research: Student Workshop on Epidemiologic Methods
1995 American Society for Preventive Oncology: New Investigators Workshop
1990 US Public Health Service: Achievement Medal
1990 US Public Health Service: Citation
1986 Boston University: Dean's Citation for Student Leadership

Outcomes of Prostate Cancer Androgen Deprivation Therapy
04/02/2010 - 07/31/2014 (PI)
Henry Ford Health System NIH NCI
5R01 CA014294-03

Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
04/01/2010 - 04/30/2014 (PI)
Henry Ford Health System NIH NCI

Long-term Survivorship in Older Women with Early stage Breast Cancer
10/01/2009 - 07/31/2013 (PI)
Boston Medical Center Corporation NIH NCI

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Alford SH, Divine G, Chao C, Habel LA, Janakiraman N, Wang Y, Feigelson HS, Scholes D, Roblin D, Epstein MM, Engel L, Havstad S, Wells K, Yood MU, Fortuny J, Johnson CC. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer Causes Control. 2018 Jan; 29(1):143-156. PMID: 29192350.
  2. Johnson CC, Jankowski M, Rolnick S, Yood MU, Alford SH. Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes. Am J Clin Oncol. 2017 Aug; 40(4):370-374. PMID: 25503426.
  3. Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 Aug 01; 141(3):480-487. PMID: 28425616; DOI: 10.1002/ijc.30745;.
  4. Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky AL. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 Jun; 197(6):1448-1454. PMID: 28007467.
  5. McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, Yood MU, Alford SH. Statin use and risk of hepatocellular carcinoma in a U.S. population. Cancer Epidemiol. 2014 Oct; 38(5):523-7. PMID: 25113938; PMCID: PMC4188715; DOI: 10.1016/j.canep.2014.06.009;.
  6. Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM. Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat. 2014 Jul; 146(2):401-9.View Related Profiles. PMID: 24939060; PMCID: PMC4506645; DOI: 10.1007/s10549-014-3021-8;.
  7. Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8. PMID: 22643199; PMCID: PMC3482414; DOI: 10.1097/MLR.0b013e31825a8c22;.
  8. Yardley DA, Kaufman PA, Brufsky A, Yood MU, Rugo H, Mayer M, Quah C, Yoo B, Tripathy D. Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer. Breast Cancer Res Treat. 2014 Jun; 145(3):725-34. PMID: 24706168; PMCID: PMC4031392; DOI: 10.1007/s10549-014-2916-8;.
  9. Lash TL, Thwin SS, Yood MU, Geiger AM, Bosco J, Quinn VP, Field TS, Pawloski PA, Silliman RA. Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer. Breast Cancer Res Treat. 2014 Apr; 144(3):643-63.View Related Profiles. PMID: 24584822; DOI: 10.1007/s10549-014-2885-y;.
  10. Amiri L, Cassidy-Bushrow AE, Dakki H, Li J, Wells K, Oliveria SA, Yood MU, Thomas A, Lanfear DE. Patient characteristics and participation in a genetic study: a type 2 diabetes cohort. J Investig Med. 2014 Jan; 62(1):26-32. PMID: 24379022; PMCID: PMC3978128; DOI: 10.231/JIM.0000000000000022;.
Showing 10 of 97 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 97 publications over 24 distinct years, with a maximum of 17 publications in 2007

Contact for Mentoring:

715 Albany St Talbot Building
Boston MA 02118
Google Map

Yood's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department